Patents by Inventor William H. Cross, III

William H. Cross, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883425
    Abstract: The invention provides compositions and methods to treat diabetes with improved formulations in which metformin is combined with at least three antioxidants that contain a stabilizing heteroatom adjacent to a saturated carbon and which help maintain a balance between antioxidant and pro-oxidant properties. The antioxidants include at least the combination of taurine, citrulline and methylcobalamin, and optionally include melatonin. The composition provides management of blood glucose levels comparable to metformin in the same dose without antioxidants, without the phenomenon of undermining metformin performance that is commonly observed in the presence of co-administered antioxidants.
    Type: Grant
    Filed: April 18, 2022
    Date of Patent: January 30, 2024
    Inventor: William H. Cross, III
  • Publication number: 20230310461
    Abstract: Described herein are compositions and methods to treat and prevent development of prediabetes. In particular, the present invention has discovered that combining certain diverse types of antioxidants yields synergistic and surprising effects against prediabetes. These antioxidant types include: heteroatom-based antioxidants from a particular chemical structural antioxidants with a conjugated segment of alternating single and double bonds; antioxidants with a disulfide bond; and antioxidants having a flavan-3-ol skeleton. It has further been discovered that it is beneficial to include one or more antioxidants that facilitates an oxidative balance.
    Type: Application
    Filed: June 6, 2023
    Publication date: October 5, 2023
    Inventor: William H. Cross, III
  • Patent number: 11612632
    Abstract: The invention provides compositions and methods to treat prediabetes. In particular, the invention has discovered that particular combinations of diverse types of antioxidants have synergistic and surprising effects for use against prediabetes. The diverse types of antioxidants include: antioxidants that comprise stabilizing heteroatoms; antioxidants with conjugated segments of alternating single and double bonds; antioxidants with disulfides; and antioxidants with phenolic groups. In particularly useful embodiments one or more of the antioxidants that comprise stabilizing heteroatoms have pro-oxidant effects, e.g., in the liver.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: March 28, 2023
    Inventor: William H. Cross, III
  • Publication number: 20220305047
    Abstract: The invention provides compositions and methods to treat diabetic neuropathies. In particular the invention has discovered that, in combination with a folic compound, particular combinations of two types of additional antioxidants have complementary effects for use against diabetic neuropathies. These include antioxidants that comprise stabilizing heteroatoms and antioxidants with an extended conjugated segment, where at least one of the antioxidants that comprises a stabilizing heteroatom also has pro-oxidant effects.
    Type: Application
    Filed: June 6, 2022
    Publication date: September 29, 2022
    Inventor: William H. Cross, III
  • Publication number: 20220233574
    Abstract: The invention provides compositions and methods to treat diabetes with improved formulations in which metformin is combined with at least three antioxidants that contain a stabilizing heteroatom adjacent to a saturated carbon and which help maintain a balance between antioxidant and pro-oxidant properties. The antioxidants include at least the combination of taurine, citrulline and methylcobalamin, and optionally include melatonin. The composition provides management of blood glucose levels comparable to metformin in the same dose without antioxidants, without the phenomenon of undermining metformin performance that is commonly observed in the presence of co-administered antioxidants.
    Type: Application
    Filed: April 18, 2022
    Publication date: July 28, 2022
    Inventor: William H. Cross, III
  • Patent number: 11351188
    Abstract: The invention provides compositions and methods to treat diabetic neuropathies. In particular the invention has discovered that, in combination with a folic compound, particular combinations of two types of additional antioxidants have complementary effects for use against diabetic neuropathies. These include antioxidants that comprise stabilizing heteroatoms and antioxidants with an extended conjugated segment, where at least one of the antioxidants that comprises a stabilizing heteroatom also has pro-oxidant effects.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: June 7, 2022
    Inventor: William H. Cross, III
  • Patent number: 11304971
    Abstract: The invention provides compositions and methods to treat diabetes with improved formulations in which metformin is combined with at least three antioxidants that contain a stabilizing heteroatom adjacent to a saturated carbon and which help maintain a balance between antioxidant and pro-oxidant properties. The antioxidants include at least the combination of taurine, citrulline and methylcobalamin, and optionally include melatonin. The composition provides management of blood glucose levels comparable to metformin in the same dose without antioxidants, without the phenomenon of undermining metformin performance that is commonly observed in the presence of co-administered antioxidants.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: April 19, 2022
    Inventor: William H. Cross, III
  • Publication number: 20220000822
    Abstract: The invention provides compositions and methods to treat diabetic neuropathies. In particular, the invention provides combinations of at least two types of antioxidants have complementary effects for use against diabetic neuropathies. The two types of antioxidants include: antioxidants that comprise stabilizing heteroatoms and antioxidants with extended conjugated segments in a ring structure. At least one of each type of provided antioxidant has a pro-oxidative or conditionally pro-oxidative effect.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 6, 2022
    Inventor: William H. Cross, III
  • Patent number: 11154523
    Abstract: The invention provides compositions and methods to treat diabetic neuropathies. In particular, the invention provides combinations of at least two types of antioxidants have complementary effects for use against diabetic neuropathies. The two types of antioxidants include: antioxidants that comprise stabilizing heteroatoms and antioxidants with extended conjugated segments in a ring structure. At least one of each type of provided antioxidant has a pro-oxidative or conditionally pro-oxidative effect.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: October 26, 2021
    Inventor: William H. Cross, III
  • Patent number: 11040022
    Abstract: The invention provides pharmaceutical compositions having improved effects and synergistic efficacy against pain, and provides methods for their use to treat pain, wherein the composition comprises: a sulfur-containing amino acid; a carnitine compound; and at least one compound that is a L-citrulline compound or a beta-alanine compound.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: June 22, 2021
    Inventor: William H. Cross, III
  • Publication number: 20190275154
    Abstract: The invention provides topical compositions and methods to treat diabetic neuropathies. Compositions of the invention comprise: aqueous solvent mixtures; natural polyamides comprising large amounts of small amino acid residues; compounds characteristic of biosynthesis and metabolism of L-carnitine, carnosine, vitamin D3, vitamin B5 and vitamin B6; purines and their decomposition compounds; and coenzyme Q10.
    Type: Application
    Filed: February 22, 2019
    Publication date: September 12, 2019
    Inventor: William H. Cross, III
  • Publication number: 20190231807
    Abstract: The invention provides compositions and methods to treat diabetic neuropathies. In particular the invention has discovered that, in combination with a folic compound, particular combinations of two types of additional antioxidants have complementary effects for use against diabetic neuropathies. These include antioxidants that comprise stabilizing heteroatoms and antioxidants with an extended conjugated segment, where at least one of the antioxidants that comprises a stabilizing heteroatom also has pro-oxidant effects.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 1, 2019
    Inventor: William H. Cross, III
  • Publication number: 20190231725
    Abstract: The invention provides compositions and methods to treat diabetic neuropathies. In particular, the invention provides combinations of at least two types of antioxidants have complementary effects for use against diabetic neuropathies. The two types of antioxidants include: antioxidants that comprise stabilizing heteroatoms and antioxidants with extended conjugated segments in a ring structure. At least one of each type of provided antioxidant has a pro-oxidative or conditionally pro-oxidative effect.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 1, 2019
    Inventor: William H. Cross, III
  • Publication number: 20190231806
    Abstract: The invention provides compositions and methods to treat diabetes with improved formulations in which metformin is combined with at least three antioxidants that contain a stabilizing heteroatom adjacent to a saturated carbon and which help maintain a balance between antioxidant and pro-oxidant properties. The antioxidants include at least the combination of taurine, citrulline and methylcobalamin, and optionally include melatonin. The composition provides management of blood glucose levels comparable to metformin in the same dose without antioxidants, without the phenomenon of undermining metformin performance that is commonly observed in the presence of co-administered antioxidants.
    Type: Application
    Filed: January 31, 2019
    Publication date: August 1, 2019
    Inventor: William H. Cross, III
  • Publication number: 20180303896
    Abstract: The invention provides compositions and methods to treat prediabetes. In particular, the invention has discovered that particular combinations of diverse types of antioxidants have synergistic and surprising effects for use against prediabetes. The diverse types of antioxidants include: antioxidants that comprise stabilizing heteroatoms; antioxidants with conjugated segments of alternating single and double bonds; antioxidants with disulfides; and antioxidants with phenolic groups. In particularly useful embodiments one or more of the antioxidants that comprise stabilizing heteroatoms have pro-oxidant effects, e.g., in the liver.
    Type: Application
    Filed: April 25, 2017
    Publication date: October 25, 2018
    Inventor: William H. Cross III
  • Publication number: 20170312329
    Abstract: The invention provides compositions and methods to treat prediabetes. In particular, the inventor has discovered that particular combinations of diverse types of antioxidants have synergistic and surprising effects for use against prediabetes. The composition includes: a plurality of heteroatom-based antioxidants having the formula X—CH2—CH(R)—(CH2)m—Z; a plurality of antioxidants with a conjugated segment; an antioxidant that is a flavan-3-ol; and an antioxidant that contains a disulfide bond. The antioxidants are chosen such that at least one has a pro-oxidative effect.
    Type: Application
    Filed: July 14, 2017
    Publication date: November 2, 2017
    Inventor: William H. Cross, III
  • Publication number: 20160228409
    Abstract: The invention provides pharmaceutical compositions having improved effects and synergistic efficacy against pain, and provides methods for their use to treat pain, wherein the composition comprises: a sulfur-containing amino acid; a carnitine compound; and at least one compound that is a L-citrulline compound or a beta-alanine compound.
    Type: Application
    Filed: February 5, 2016
    Publication date: August 11, 2016
    Inventor: William H. Cross, III